from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3190c/-

LFCtreatmentdescriptionclass of inhibitor

-1.217

Amikacinug/mL Amikacintranslation

0.482

Cap5-10ug/mL Capreomycintranslation

-0.009

Rox10-50 ug/mL Roxithromycintranslation

0.235

SM2-5 ug/mL Streptomycintranslation

0.490

Tet5-10 ug/mL Tetracyclinetranslation

-1.812

Rif0.2-5ug/mL Rifampicintranscription

-1.051

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.572

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.047

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.155

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.416

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.491

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.286

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.650

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.071

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.452

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.190

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.809

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.019

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.417

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.294

KCN5-20 ug/mL Potassium cyaniderespiration

-1.487

NaN30.2-2 mM Sodium aziderespiration

1.004

Nigericin50 uM Nigericinrespiration

-0.008

TRC10-150 ug/mL Triclosanrespiration

0.771

TRZ10-25 ug/mL Thioridazinerespiration

-0.024

Valinomycin0.5-10 uM Valinomycinrespiration

-0.926

ZnSO42 mM ZnSO4respiration

1.159

menadione6-10 ug/mL Menadionerespiration

-0.098

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.001

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.483

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.250

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.184

NRP_1Non-replicating persistence stage 1dosRassociated

0.726

Amp0.2mg/mL AmpicillincellWall

0.602

Cephalexin20-100 ug/mL CephalexincellWall

-0.016

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.236

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.397

EMB10-20 ug/mL EthambutolcellWall

0.304

Eta12-40 ug/mL EthionamidecellWall

0.129

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.619

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.070

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.440

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.636

BZA0.12 mg/mL BenzamidearomaticAmides

-0.723

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.155

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.202

H2O24 mM hydrogen peroxideDNAdamaging

1.168

Levo10 ug/mL LevofloxacinDNAdamaging

0.215

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.163

Novobiocin10 ug/mL NovobiocinDNAdamaging

2.679

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.418

UVUV-irradiationDNAdamaging

0.669

ARP41-4 ug/mL Antitubercular compound ARP4?

0.017

Antimycin12.5-50 ug/mL Antimycin A?

0.833

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.649

PA_110-50 ug/mL Antitubercular compound PA-1?

0.223

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.731

PA8240.2-2 ug/mL PA-824?

-0.594

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.471

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.479

Verapamil50 uM Verapamil?

-0.254

mercaptoethanol2 mM 2-Mercaptoethanol?

0.460

methoxatin10-20 ug/mL Methoxatin?